Recent Finacing
Recent Raise
Fluent BioSciences develops low-cost, high-throughput single-cell RNA sequencing kits for million-cell transcriptome profiling, leveraging Ultima Genomics sequencing and shipping prototype kits toward commercialization.
Focus Areas
Recent Investors
Funding round
Investor
See the team members at Fluent BioSciences.
